D Vetter

662 total citations
30 papers, 514 citations indexed

About

D Vetter is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, D Vetter has authored 30 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 16 papers in Hepatology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in D Vetter's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease and Transplantation (6 papers). D Vetter is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease and Transplantation (6 papers). D Vetter collaborates with scholars based in France, Switzerland and Belgium. D Vetter's co-authors include Jean-Frédéric Westphal, J.M. Brogard, Michel Doffoël, Jean-Jacques Wenger, B. Cribier, Françoise Stoll‐Keller, George R. Uhl, Jean-Marie Lang, P Deyhle and D. Rey and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Clinical Infectious Diseases.

In The Last Decade

D Vetter

29 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Vetter France 9 260 221 68 62 60 30 514
M Pirovino Switzerland 16 275 1.1× 262 1.2× 185 2.7× 83 1.3× 34 0.6× 51 674
Dimitrios Siagris Greece 13 314 1.2× 435 2.0× 105 1.5× 56 0.9× 48 0.8× 29 680
A. Escudero Spain 12 307 1.2× 328 1.5× 129 1.9× 67 1.1× 31 0.5× 29 563
G Visco Italy 12 176 0.7× 160 0.7× 56 0.8× 38 0.6× 37 0.6× 35 538
Kung‐Chia Young Taiwan 10 291 1.1× 290 1.3× 65 1.0× 153 2.5× 32 0.5× 16 630
Haruyuki Hayashi Japan 14 368 1.4× 306 1.4× 67 1.0× 76 1.2× 28 0.5× 25 556
Y Yajima Japan 11 237 0.9× 245 1.1× 109 1.6× 47 0.8× 13 0.2× 35 537
Carol Goulding Ireland 9 139 0.5× 152 0.7× 63 0.9× 42 0.7× 33 0.6× 15 434
Zsuzsanna Vitális Hungary 13 289 1.1× 352 1.6× 109 1.6× 61 1.0× 25 0.4× 34 544
Alberto Muñoz Argentina 14 527 2.0× 490 2.2× 181 2.7× 31 0.5× 56 0.9× 26 748

Countries citing papers authored by D Vetter

Since Specialization
Citations

This map shows the geographic impact of D Vetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Vetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Vetter more than expected).

Fields of papers citing papers by D Vetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Vetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Vetter. The network helps show where D Vetter may publish in the future.

Co-authorship network of co-authors of D Vetter

This figure shows the co-authorship network connecting the top 25 collaborators of D Vetter. A scholar is included among the top collaborators of D Vetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Vetter. D Vetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rutgeerts, Paul, Antoine Cortot, G. D’Haens, et al.. (2004). Effects of natalizumab on gut healing in a phase 3 study of active Crohn's disease therapy (ENACT-1). Gastroenterology. 9 indexed citations
2.
Geboes, Karel, Antoine Cortot, G. D’Haens, et al.. (2004). Natalizumab decreases inflammatory cells within the colonic lamina propria of patients with active Crohn's disease: results from ENACT-1. Gastroenterology. 3 indexed citations
3.
Shiffman, M., Patrick Marcellin, L. Jeffers, et al.. (2004). 45 HBsAg seroconversion in adefovir dipivoxil (ADV) treated chronic hepatitis B (CHB) patients. Journal of Hepatology. 40. 17–17. 12 indexed citations
4.
Cribier, B., George R. Uhl, Carine Schmitt, et al.. (1999). Follow-up of hepatitis C virus RNA in peripheral blood mononuclear cells during interferon therapy. Archives of Virology. 144(2). 355–364. 8 indexed citations
5.
Cribier, B., Carine Schmitt, D. Rey, et al.. (1997). HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype. Research in Virology. 148(4). 267–271. 44 indexed citations
6.
Jaeck, D, P. Bachellier, Laurence Choné, et al.. (1997). Comparison of resection, liver transplantation and transcatheter oily chemoembolisation in the treatment of hepatocellular carcinoma.. PubMed. 50 Suppl 1 Pt 1. 413–5. 1 indexed citations
7.
Doffoël, M, et al.. (1997). [Chemoembolization of hepatic metastases of small intestine leiomyosarcoma. 2 cases].. PubMed. 21(3). 235–6. 1 indexed citations
8.
Cribier, B., George R. Uhl, Carine Schmitt, et al.. (1996). Quantification of hepatitis C virus RNA in peripheral blood mononuclear cells: a comparison between patients chronically infected by HCV and patients coinfected by HIV. Research in Virology. 147(6). 325–332. 7 indexed citations
9.
Cribier, B., P Petiau, Françoise Stoll‐Keller, et al.. (1996). [Porphyria cutanea tarda and hepatitis C virus infection. Clinical and virological study].. PubMed. 123(3). 200–2. 7 indexed citations
10.
Westphal, Jean-Frédéric, D Vetter, & J.M. Brogard. (1994). Hepatic side-effects of antibiotics. Journal of Antimicrobial Chemotherapy. 33(3). 387–401. 139 indexed citations
11.
Westphal, Jean-Frédéric, F. Jehl, & D Vetter. (1994). Pharmacological, Toxicologic, and Microbiological Considerations in the Choice of Initial Antibiotic Therapy for Serious Infections in Patients with Cirrhosis of the Liver. Clinical Infectious Diseases. 18(3). 324–335. 24 indexed citations
12.
Vetter, D, et al.. (1994). [Autoimmune hepatitis. New pathophysiological and clinical aspects].. PubMed. 18(5). 429–36. 2 indexed citations
13.
Folkins, John W., Michael P. Gorga, Erich S. Luschei, D Vetter, & Charles S. Watson. (1993). The use of nonhuman animals in speech, language, and hearing research.. PubMed. 35(4). 57–65. 3 indexed citations
14.
Vetter, D, et al.. (1991). Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients.. PubMed. 13(3). 427–33. 121 indexed citations
15.
Doffoël, M, et al.. (1989). Une cause rare de syndrome inflammatoire isolé:la maladie de whipple. La Revue de Médecine Interne. 10(1). 57–58. 3 indexed citations
16.
Doffoël, M, et al.. (1989). Results of orthotopic liver transplantation (OLT) in alcoholic cirrhosis. Journal of Hepatology. 9. S27–S27. 2 indexed citations
17.
Vetter, D, et al.. (1989). [In vitro demonstration of a deficit in suppressor T-cell function in alcoholic cirrhosis. Role of hepatitis B virus infection].. PubMed. 13(1). 60–5. 1 indexed citations
18.
Vetter, D, et al.. (1988). [Study of insulin resistance in cirrhosis by the hyperinsulin euglycemia clamp].. PubMed. 12(5). 473–7. 1 indexed citations
19.
Vetter, D, et al.. (1976). Gastrointestinal involvement in systemic mastocytosis.. Gut. 17(2). 107–112. 55 indexed citations
20.
Knoblauch, M, et al.. (1973). [Subacute necrotizing hepatitis].. PubMed. 14(11). 596–603. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026